Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer

BACKGROUND: Gemcitabine (2′, 2′ –difluorodeoxycytidine) is one of many nonplatinum drugs that exhibit activity in recurrent, platinum-resistant ovarian cancer. However, the molecular mechanisms by which Gemcitabine treatment inhibits the proliferation of platinum-resistant ovarian cancer cells still...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Hiroshi, Terai, Yoshito, Tanabe, Akiko, Sasaki, Hiroshi, Takai, Masaaki, Fujiwara, Satoe, Ashihara, Keisuke, Tanaka, Yoshimichi, Tanaka, Tomohito, Tsunetoh, Satoshi, Kanemura, Masanori, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234938/
https://www.ncbi.nlm.nih.gov/pubmed/24713296
http://dx.doi.org/10.1186/1757-2215-7-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234938/
https://www.ncbi.nlm.nih.gov/pubmed/24713296
http://dx.doi.org/10.1186/1757-2215-7-38

Ejemplares similares